Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2.

Liu, Zuqiang; Ge, Yan; Wang, Haiyan; Ma, Congrong; Feist, Mathilde; Ju, Songguang; Guo, Z Sheng; Bartlett, David L

Liu, Zuqiang; Ge, Yan; Wang, Haiyan; Ma, Congrong; Feist, Mathilde; Ju, Songguang; Guo, Z Sheng; Bartlett, David L.

Affiliation

Liu Z; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Ge Y; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.
Wang H; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Ma C; Department of Immunology, School of Biology and Basic Medical Sciences, Medical College, Soochow University, Suzhou, 215123, Jiangsu Province, China.
Feist M; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Ju S; Department of Immunology, School of Biology and Basic Medical Sciences, Medical College, Soochow University, Suzhou, 215123, Jiangsu Province, China.
Guo ZS; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Bartlett DL; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.

Nat Commun ; 9(1): 4682, 2018 11 08.

Article in En | MEDLINE | ID: mdl-30410056

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia virus / Interleukin-2 / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google